General Information
Product name
Cefotaxime Sodium
CAS No.
64485-93-4
1.2.1 Relevant identified uses
For research purposes only
Emergency telephone
+44(0)1485 609069
Icons in SDS
Company Information
company name
Formedium Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@formedium.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation EC 1272/2008 (CLP) Classification of the substance or mixture
Hazard categories
Respiratory Sensitization Category 1, H334 Skin Sensitization Category 1, H317 Hazard Statements H317 - May cause an allergic skin reaction H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled
Hazardous Ingredients
Sodium [6r-[6α,7β(z)]]-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)(methoxyimi no)acetamido]-8-oxo5-thia-1- azabicyclo[4.2.0]oct-2-ene CEF SECTION 2 Hazards identification (continued)
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust. P280 Wear protective gloves. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/ physician.
2.3 Other hazards
None under normal conditions.
2.1 Classification of the substance or mixture
Regulation (EC) No. 1272 / 2008 Hazard categories: Respiratory Sensitization : Category 1, H334 Skin Sensitization : Category 1, H317 Hazard Statements: H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
